[EN] THERAPEUTICALLY ACTIVE FUSED PYRIMIDINE DERIVATIVES<br/>[FR] DÉRIVÉS DE PYRIMIDINE FUSIONNÉS À ACTIVITÉ THÉRAPEUTIQUE
申请人:UCB PHARMA SA
公开号:WO2013024291A2
公开(公告)日:2013-02-21
A series of monocyclic or bicyclic diamine-substituted thieno[2,3-d]pyrimidine and isothiazolo[5,4-d]pyrimidine derivatives are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases; and organ and cell transplant rejection.